Based in Vienna, this organizational unit supports, connects, and enables the entire sales and marketing activities of the Chiesi Group in the CEE- and CIS-region as well as in Austria.
Based in Vienna, this organizational unit supports, connects, and enables the entire sales and marketing activities of the Chiesi Group in the CEE- and CIS-region as well as in Austria.
Revolutionizing the lives of patients with rare diseases. As part of the broader Chiesi Group, we believe patients are at the heart of what we do. That’s why our journey (and commitment) begins with and centers on patients. We work in close partnership with patients, caregivers, medical, educational, and governmental entities to ensure regulatory, environmental, and pricing practices are beneficial to the patients we serve and every one of us.
We believe in passion, courage, teamwork, and innovation.
Our mission is to become a point of reference for all patients affected by rare diseases by 2025, to build a better future for patients, and to continue exploring new frontiers of treatment and care.
Chiesi is the largest global pharmaceutical company to be awarded B Corporation Certification, a recognition of high social and environmental standards. It’s an achievement to be proud of, and yet it feels natural: caring for others is at the root of health science, and it has always been at the core of our work.
B Corporations are businesses that balance purpose with profit. With this status, we are legally required to consider the impact of our decisions on our employees, customers, suppliers, community, and the environment. This is a global movement of people using business as a force for good.
This means that we make uncommon decisions, which other companies might not take, and decisions that do not necessarily benefit the short-term income statement of the company.
While sustainability has always been important to Chiesi, today it is part of our strategic plan. This means we are committed to improving patient quality of life, protecting the planet and its inhabitants, supporting our communities, promoting the development of our people, and guaranteeing maximum transparency in the way we work. Read more about our Corporate Social Responsibility.
Patients are at the beginning and end of our journey—that’s why we apply so much focus to science and innovation. We engage in a wide dialogue beyond treatment to understand the needs of individuals, their families, and the community so we can imbed your voice in our development process. We promise to keep researching, enhancing, and advancing new products, whether internally or through partnerships, so people impacted by rare diseases can find the care they need.
Providens d.o.o. Zagreb, Representative office in Macedonia
